Another solid quarter- 6th in a row? Strong, improving data and compelling narrative which is what one can expect from management. A conversion from Fuji (mega player in biopharma space building mega facilities too across therapies, biologicals etc) would be a share price booster, but its also great to see the depth of customers driving sales outside that so this is not a one trick poney..
A lot to look forward and one of the few genuine 10-20x bagger i can see on the ASX that does not rely on random drilling success.
Another solid quarter- 6th in a row? Strong, improving data and...
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.705M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $6.449K | 924.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 2870001 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 267941 | 1 |
View Market Depth
| Last trade - 15.05pm 03/05/2024 (20 minute delay) ? |
| BCT (ASX) Chart |